The major trends, which have an impact on demand for botanical medicines and, consequently, the demand for natural pharmaceutical ingredients, include, amongst others:• Interest of individuals, communities and national governments in greater self-reliance in health care; • The entry of large pharmaceutical and Over-The-Counter (OTC) companies has placed botanical medicines more strongly on the mass market;• Increasing success in validating the safety and efficacy of herbal remedies;• Legislation improving the status of the herbal medicine industry.
Current programmes
There are no running programmes for this sector at this time. To view a list of all programmes, click here
News
-
Peruvian agriculture companies are heading for Europe: IADB and CBI contribute to Peruvian seminar
Peruvian agro-business companies are highly interested to know more about U.S. and E.U. fito... -
CBI in Moldova
CBI in MoldovaIn 2007, the Moldovan Ministry of Economy invited CBI to... -
Palestinian exports need unlocking
-
Navigating Pharmaceutical Requirements
CBI is increasing its support to pharmaceutical producers in developing countries (DCs) with a...
Market Information
- WHO Guidelines on good agricultural and collection practices medicinal plants
- Exploring E-business: much to g@in for exporters of natural ingredients
- Natural ingredients for pharmaceuticals (NIP): introduction to CBI's market information
LINKS
CBI services
Export Coaching Programmes
Multi-year programmes for enterprises wishing to export to the European Union.
BSO Development Programmes
Capacity Development for intermediate organisations that support exporters to export to the European Union.
Training Programmes
Seminars and workshops on exporting to the European Union for exporters, staff of intermediate organisations and commercial attachés.
Company Database
A database of companies CBI has coached to become competent exporters to the European Union.
Market Intelligence
All the information to keep exporters and staff of BSOs in step with the latest developments on the EU market.
